BMC Pediatrics | |
Intracranial hypertension presenting with severe visual failure, without concurrent headache, in a child with nephrotic syndrome | |
Ming Lim1  Danny Morrison3  Manish D Sinha2  Madeleine Barnett1  | |
[1] Children’s Neurosciences, Evelina Children’s Hospital at Guy’s and St Thomas’ NHS Foundation Trust, King’s Health Partners Academic Health Science Centre, Westminster Bridge Road, London, SE1 7EH, England;Paediatric Nephrology, Evelina Children’s Hospital at Guy’s and St Thomas’ NHS Foundation Trust, King’s Health Partners Academic Health Science Centre, Westminster Bridge Road, London, SE1 7EH, England;Paediatric Ophthalmology, Evelina Children’s Hospital at Guy’s and St Thomas’ NHS Foundation Trust, King’s Health Partners Academic Health Science Centre, Westminster Bridge Road, London, SE1 7EH, England | |
关键词: Cyclosporine; Papilloedema; Optic atrophy; Idiopathic intracranial hypertension; Benign intracranial hypertension; Pseudotumour cerebri; | |
Others : 1144388 DOI : 10.1186/1471-2431-13-167 |
|
received in 2013-06-21, accepted in 2013-10-10, 发布年份 2013 | |
【 摘 要 】
Background
Idiopathic intracranial hypertension is a condition typically characterised by headache, normal level of consciousness, papilloedema and raised cerebrospinal fluid pressure. Children often present with visual loss and atypical features of raised pressure, posing a diagnostic and management challenge. A range of renal disorders can predispose to developing this raised intracranial pressure syndrome. We present a case of severe visual failure in a child with nephrotic syndrome, with no headache when elevated pressure was proven. In nephrotic syndrome, visual failure related to elevated intracranial pressures without concurrent headache symptoms has not been reported previously.
Case presentation
We discuss a 5-year-old Caucasian girl with steroid sensitive nephrotic syndrome who went on to become a late non-responder and presented with intracranial hypertension. Following initial response to steroids, she had a relapse of her nephrotic syndrome; her proteinuria did not resolve on steroid treatment, requiring addition of cyclosporine therapy to manage her nephrotic syndrome. Three months following this, she presented with visual failure in the right eye with bilateral central scotoma and papilloedema. At the time of presentation of visual impairment, she was otherwise well, with no symptoms of a raised intracranial pressure syndrome or associated systemic illness. Medical management was initiated following confirmation of a raised intracranial pressure. Her intracranial pressure remained elevated requiring serial therapeutic lumbar punctures before some improvement in visual acuity was observed. Later in the clinical course, she presented with worsening of her visual impairment with further deterioration of the vision in the left eye, again associated with elevated intracranial pressure. An urgent surgical cerebrospinal fluid diversion procedure was performed. At review, three years after presentation our patient has severe visual impairment with no perception of light in her right eye and 6/36 Snellen acuity in the left secondary to optic atrophy.
Conclusion
Our case demonstrates the occurrence of intracranial hypertension in nephrotic syndrome, highlighting the atypical presentation of severe visual failure without concurrent headache at presentation. This demonstrates the management complexities and the need for clear guidelines for ophthalmological surveillance to aim to reduce permanent visual impairment.
【 授权许可】
2013 Barnett et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20150330132149966.pdf | 136KB | download |
【 参考文献 】
- [1]Gordillo R, Spitzer A: The nephrotic syndrome. Pediatr Rev 2009, 30(Suppl 3):94-104. quiz 105
- [2]Gong WK, Cheung W, Yap HK: Minimal change nephrotic syndrome--a complex genetic disorder. Ann Acad Med Singapore 2000, 29(Suppl 3):351-356.
- [3]Friedman DI, Jacobson DM: Idiopathic intracranial hypertension. J Neuroophthalmol 2004, 24(Suppl 2):138-145.
- [4]Avery RA, Shah SS, Licht DJ, Seiden JA, Huh JW, Boswinkel J, Ruppe MD, Chew A, Mistry RD, Liu GT: Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med 2010, 26(363):891-893.
- [5]Wall M: Idiopathic Intracranial Hypertension. Neurol Clin 2010, 28(Suppl 3):593-617.
- [6]Lim M, Kurian M, Penn A, Calver D, Lin JP: Visual failure without headache in idiopathic intracranial hypertension. Arch Dis Child 2005, 90(2):206-210.
- [7]Rangwala LM, Liu GT: Pediatric idiopathic Intracranial Hypertension. Survey Of Ophthalmology 2007, 52:597-617.
- [8]Costa KM, Almeida JB, Félix RH, Silva Júnior MF: Pseudotumor cerebri associated with cyclosporin use following renal transplantation. J Bras Nefrol 2010, 32:136-139.
- [9]Noetzel MJ, Rioux SD: Pseudotumor cerebri associated with obstructive nephropathy. Pediatr Neurol 1986, 2(Suppl 4):238-240.
- [10]Yang GF, Schoepf UJ, Zhu H, Lu GM, Gray JC III, Zhang LJ: Thromboembolic complications in nephrotic syndrome: imaging spectrum. Acta Radiol 2012, 1(53):1186-1194.
- [11]Biousse V, Ameri A, Bousser MG: Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999, 22(53):1537-1542.
- [12]Digre KB, Corbett JJ: Idiopathic intracranial hypertension (pseudotumour cerebri): a reappraisal. Neurologist 2001, 7:2-67.
- [13]De Benedetto U, Pastore MR, Battaglia Parodi M, Bandello F, Pierro L: Retinal involvement in nephrotic syndrome secondary to minimal change disease. Eur J Ophthalmol 2012, 22(Suppl 5):843-845.
- [14]Gupta M, Bansal R, Beke N, Gupta A: Tacrolimus-induced unilateral ischaemic optic neuropathy in a non-transplant patient. BMJ Case Rep 2012, 2012:21.
- [15]Gwer S, Sheward V, Birch A, Marchbanks R, Idro R, Newton CR, Kirkham FJ, Lin JP, Lim M: The tympanic membrane displacement analyser for monitoring intracranial pressure in children. Childs Nerv Syst 2013, 29(6):927-933.
- [16]Ghosh S, Sarkar K, Mukhopadhyay S, Bhaduri G: Idiopathic intracranial Hypertension in a child after hemodialysis. Pediatr Neurol 2008, 39(4):272-5.